Radioembolization of yttrium-90 microspheres for hepatic malignancy

Ravi Murthy*, Parash Kamat, Rodolfo Nunez, Riad Salem

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations


The liver represents a frequent site for primary and secondary neoplasia. Cytoreductive techniques positively influence the outcome of disease progression in these patients. Transhepatic arterial radioembolotherapy utilizing yttrium-90 microspheres represents a recently available in situ therapy that has shown encouraging results in the treatment of these patients. Harnessing the skills of many different specialties, such as interventional radiology, surgical oncology, medical oncology, nuclear medicine, radiation oncology, medical physics, and radiation safety, brings invaluable expertise to the treatment process for a safe and effective radioembolization treatment program.

Original languageEnglish (US)
Pages (from-to)48-57
Number of pages10
JournalSeminars in Interventional Radiology
Issue number1
StatePublished - Mar 2008


  • Liver cancer
  • Radioembolization
  • Yttrium-90

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Radioembolization of yttrium-90 microspheres for hepatic malignancy'. Together they form a unique fingerprint.

Cite this